Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Qualitative Study on the Perception of Changes in the Psychotherapy of Traumatized Young People

NCT06138522 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2023-11-30
Last updated
2025-12-23

Condition(s) studied

Post-traumatic Stress Disorder

Investigational drug(s) / intervention(s)

Semi-structured interviewsChild Post-Traumatic Stress Response Index (CPTS-RI) scale- Therapeutic Alliance Questionnaire (HAQ-CP)

Semi-structured interviews: Semi-structured interviews

Child Post-Traumatic Stress Response Index (CPTS-RI) scale: Child Post-Traumatic Stress Response Index (CPTS-RI) scale

- Therapeutic Alliance Questionnaire (HAQ-CP): \- Therapeutic Alliance Questionnaire (HAQ-CP)

Study summary

The clinic of psychological trauma in adolescents still requires further development, whereas it is well documented in adults. This clinic is complex, because it must take into account the nature and type of trauma (recent or not, intentional or not, situations of abuse or sexual violence, etc.), the impact on development, the contexts (social, cultural and family) in which the trauma occurs, and the various vulnerability factors associated with it. This complexity has implications for psychotherapeutic management, which needs to be tailored to the specific clinical profiles of adolescents.

Several studies have evaluated psychotherapy for traumatized adolescents, showing a positive short-term effect on the reduction of post-traumatic stress symptoms, whatever the type of psychotherapy. Few studies, however, have analyzed the therapeutic process and the common factors of change, linked mainly to the therapeutic alliance, the patient's experience and the therapist's role: key factors of change according to the international literature. In this context, the patient's experience of his or her psychotherapeutic follow-up is a source of information that has long been neglected, even though it seems essential for better investigating and understanding the complexity of the processes at play in trauma psychotherapy.

Eligibility

Sex
ALL
Min age
12 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: Teenagers : * Teenagers from 12 to 18 years old * Post-traumatic stress disorder (DSM Criteria 5 Post-Traumatic Stress Disorder) * Consultant at the Maison de Solenn (Maison des Adolescents) * Affiliated to a social security scheme Parents : parents of adolescents followed at the MDA and agreeing to participate in the study Professionals: providing psychotherapeutic follow-up for adolescents at the MDa Exclusion Criteria: * Refusal of the adolescent and/or his/her family (if applicable) to participate in the study, * Adults (all groups combined): under guardianship or curatorship, under judicial protection

Primary outcome measure(s)

  • Semi-structured interviews — At the end of the psychotherapy (up to month 12)
    Adolescent Psychotherapy Experience = Evolution in semi-structured interviews at the beginning (T1) and end (T2) of psychotherapy (adolescents)

Trial sites (1)

FacilityCityRegionStatus
University Hospital Cochin, Maison des Adolescents - Youth Department, F-75014 Paris, France Paris IDF Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06138522 on ClinicalTrials.gov ↗ ← All trials in France